Most plant viruses and many animal viruses, which include viruses of agricultural, clinical, and veterinary importance, are positive-strand RNA viruses that have single-stranded, messenger-sense RNA genomes in virions and which replicate via negative-strand RNA [(Ϫ)RNA]. The genomes of positivestrand RNA [(ϩ)RNA] viruses each encode one or more proteins that are involved in viral RNA replication. These replication proteins are synthesized by translation of the genomic RNAs after infection. The replication proteins recruit the genomic RNA to the cytoplasmic faces of the organellar membranes specific for each virus and synthesize (Ϫ)RNA, which is sequestered in a membranous compartment that cannot be accessed by the cytoplasmic macromolecules (23, 30) . Then, large amounts of (ϩ)RNAs (genomic and, for certain viruses, subgenomic RNAs) are synthesized using the (Ϫ)RNA as a template and are released into the cytoplasm (2, 30) . In this report, we designate this membrane-bound complex that harbors (Ϫ)RNA and is capable of producing (ϩ)RNA the viral RNA replication complex. For a number of positive-strand RNA viruses, it has been demonstrated that replication complexes reside in membranous invaginations called spherules or in other membranous structures formed after virus infection (30, 32) .
For Brome mosaic virus (BMV), one of the most well-characterized positive-strand RNA viruses, it was demonstrated that the viral helicase-like 1a replication protein recruits replication template RNA and the viral 2a polymerase protein to the cytoplasmic surface of the endoplasmic reticulum membranes to form the replication complex (4, 30) . Genetic and other analyses using the yeast Saccharomyces cerevisiae revealed that template recruitment by BMV 1a requires the host Lsm1p-7p/Pat1p/Dhh1p complex, which is involved in deadenylation-dependent mRNA decapping (6, 21) . The initiation of BMV negative-strand RNA synthesis requires a cochaperone, Ydj1p (33) , and depends on membrane lipid composition controlled by the ⌬9 fatty acid desaturase Ole1p (18) . For tombusviruses, other well-characterized positive-strand RNA viruses, it was shown that the p33 replication protein interacts with the p92 polymerase protein and replication template RNA (27) (28) (29) . It was suggested that a complex containing p33, p92, and template RNA is targeted to the peroxisomal membranes, where the replication complexes are formed (27) . The initiation of tombusvirus (Ϫ)RNA synthesis requires the molecular chaperone Hsp70 (31) . Even for these viruses, however, details of replication complex formation have not been revealed.
Tomato mosaic virus (ToMV) is a positive-strand RNA virus that belongs to the genus Tobamovirus, which also includes Tobacco mosaic virus (TMV). The genome of ToMV is a nonsegmented RNA of 6,384 nucleotides with a 7-methylguanosine cap at the 5Ј terminus and a tRNA-like structure at the 3Ј terminus. The ToMV genome encodes at least four proteins, of 130 kDa (130K protein), 180 kDa (180K protein), 30 kDa, and 17 kDa (coat protein). The 180K protein is synthesized by suppression of the termination codon of the 130K protein open reading frame (ORF) (3, 14, 24) . Among these four ToMV-coded proteins, only the 180K protein is necessary for viral RNA replication; the remaining three proteins are dispensable for replication. However, replacement of the termination codon of the 130K protein ORF with a tyrosine or phenylalanine codon, which results in the inhibition of 130K protein production, reduces the efficiency of viral RNA replication. Thus, balanced synthesis of the 130K and 180K proteins is necessary for efficient RNA replication (3, 11, 12, 14, 20) . In keeping with the involvement of the 130K and 180K proteins in RNA replication, these proteins contain the methyltransferase-like and helicase-like domains, as well as the C-terminal, 180K protein-specific region that harbors the polymeraselike domain (2, 16) . The ToMV 130K and 180K proteins do not have stretches of amino acid sequence that are predicted to serve as membrane-spanning regions. Nevertheless, in ToMVinfected cells, the activity of ToMV-related RNA synthesis is exclusively associated with membranes, and a fraction of the 130K and 180K protein pool is associated with membranes (9, 23) . Several lines of observation suggest that the 130K and 180K replication proteins acquire the ability to synthesize ToMV-related RNA only after multiple interactions with host membranes and proteins, with ToMV RNA, and with themselves (7, 8, 22, 23, 25, 26, (34) (35) (36) (37) . Previously, we found that extracts of evacuolated tobacco BY-2 protoplasts (BYL) were able to translate ToMV RNA to produce the 130K and 180K proteins, and when ribonucleoside triphosphates (rNTPs) were added to the mixture after translation, the ToMV (-)RNAs and (ϩ)RNAs were synthesized in a pattern similar to that observed in vivo (15) . BYL contains membranes on which the ToMV RNA replication complex is formed. In the present study, we examined membrane requirements for ToMV RNA replication in BYL and identified a ribonucleoprotein intermediate of ToMV RNA replication complex formation by following the translation of ToMV RNA in membrane-depleted BYL.
MATERIALS AND METHODS
RNA templates for in vitro translation and replication. ToMV RNA was prepared from purified virions by phenol extraction and alcohol precipitation. The other template RNAs used in this study were synthesized by in vitro transcription using the AmpliCap T7 (for TLW3, TL180SF, TL180, TL130, and D1 RNA) or SP6 (for Rluc RNA) High Yield Message Maker kit (Epicentre Technologies, Madison, WI) in the presence of the cap analog m 7 G[5Ј]ppp[5Ј]G. TLW3 RNA was synthesized from SmaI-linearized pTLW3(Sma). The pTLW3(Sma) plasmid was constructed by deleting the 3Ј-terminal A residue of the ToMV RNA sequence and the following 17-nucleotide polylinker sequence of the wild-type, full-length ToMV cDNA clone pTLW3 (17) . The nucleotide sequence of pTLW3(Sma) around the 3Ј-terminal region of ToMV RNA is as follows: 5Ј-GGCCCGGGAATTC-3Ј (ToMV RNA-derived nucleotides are shown in bold letters, the C residue that corresponds to the second nucleotide from the 3Ј terminus of ToMV RNA is underlined, and the SmaI recognition sequence is italicized). Capped in vitro transcript synthesized from SmaI-linearized pTLW3(Sma) was infectious for plants and showed similar or slightly higher efficiency of in vitro replication in BYL, compared to the corresponding transcript from MluI-linearlized pTLW3.
TL180SF RNA was synthesized from SmaI-linearized pTL180SF, a derivative of pTLW3(Sma) that encodes a FLAG-tagged 180K protein. The nucleotide sequence between the last codon (underlined) of the 180K protein-coding region and the BstEII site (italicized) located in the coat protein coding region is as follows: 5Ј-TGTGGAGAGCTCGGAGGTGATTATAAGGATGATGATGAT AAGAACTGGTCACATCCTCAATTTGAAAAGTGAGGTAACC-3Ј (the termination codon for the 180K-FLAG ORF is indicated by bold letters).
TL180 RNA, which expresses the 180K protein but not the 130K protein, was synthesized from MluI-linearized pTL180. The pTL180 plasmid is a derivative of pTLW3, in which the NheI-KpnI fragment that contains the termination codon of the 130K protein ORF has been replaced with the corresponding fragment from pLFR2 (11) .
TL130 RNA and D1 RNA are ToMV RNA derivatives that were synthesized from PCR fragments amplified using modified pTLW3 DNA templates and the following primers: 5Ј-CGCCAGGGTTTTCCCAGTCACGAC-3Ј, which corresponds to a region upstream of the T7 promoter, and 5Ј-TGGGCCCCAACCG GGGGTTC-3Ј, which anneals to the 3Ј-terminal region of the ToMV RNA sequence (nucleotides 6384 to 6361). TL130 RNA has a deletion of nucleotides 3424 to 5798, and D1 RNA has a deletion of nucleotides 1346 to 5655.
Rluc RNA was synthesized from EcoRI-linearized pMI27 (5).
In vitro translation and RNA-dependent RNA polymerase (RdRP) reaction in BYL. The cell extract of evacuolated BY-2 protoplasts was prepared as described previously (15) , using a modified TR buffer (30 mM HEPES-KOH [pH 7.4], 80 mM potassium acetate, 1.8 mM magnesium acetate, 2 mM dithiothreitol, with one tablet of Complete Mini protease inhibitor cocktail, EDTA free [Roche], added to 10 ml of TR buffer before use) (10) . The modified TR buffer was used in place of the original TR buffer throughout the experiments. To prepare membrane-depleted BYL (mdBYL), BYL (200 l) was subjected to centrifugation at 30,000 ϫ g for 15 min at 4°C in a Beckman TLA 100.3 rotor, and the supernatant (180 l) was recovered. The pellet was resuspended in the residual 20 l of supernatant to give the p30BYL membrane suspension. In vitro translation of ToMV-related and other RNAs using BYL was performed at 25°C for 1 h as described previously (10, 15) . In vitro translation was also performed under the same conditions using mdBYL in place of BYL. The RdRP reaction was performed by adding 5 l of 5ϫ R buffer (10, 15) to 20 l of each test sample and then incubating the mixture at 25°C for 1 h.
Sucrose gradient sedimentation analysis. A linear sucrose gradient was formed using 1.1 ml each of 15% and 40% (wt/vol) sucrose solutions (in 30 mM HEPES-KOH [pH 7.4], 80 mM potassium acetate, 1.8 mM EDTA, 2 mM dithiothreitol) using Gradient Mate (BioComp Instruments, Inc., Fredericton, New Brunswick, Canada) at an angle of 85°at 20 rpm for 1 min. Two hundred microliters of samples were loaded onto the sucrose gradient and subjected to centrifugation (100,000 ϫ g for 2 h at 4°C) in a Beckman TLS-55 rotor.
Protein and RNA analyses. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (PAGE) and Western analyses of protein samples were performed as described previously (9) . Total RNA samples were purified and analyzed by 8 M urea-2.4% PAGE (15) or Northern blotting and hybridization as described previously (13) . To detect ToMV (Ϫ)RNA, RNA samples were treated with S1 nuclease and subjected to the RNase protection assay using 32 P-labeled P2P RNA as the probe, as described previously (15) . S1 nuclease treatment was performed as described previously (15) .
RESULTS
Membranes are required for ToMV RNA synthesis. When ToMV RNA was translated in BYL, the 130K and 180K replication proteins were produced (Fig. 1A , lanes 1 and 2); and when rNTPs were added to the translation mixture and incubated further (hereafter referred to as the RdRP reaction; see Materials and Methods), ToMV RNA replication occurred in a pattern similar to that observed in vivo (Fig. 1B , lanes 1 and 2) (15), which suggests that the ToMV RNA replication complex is formed. To investigate the role of membranes in the formation of the ToMV RNA replication complex in this in vitro system, membranes were removed from BYL by centrifugation at 30,000 ϫ g to generate mdBYL. Translation of ToMV RNA in mdBYL yielded amounts of the 130K and Although ToMV (Ϫ)RNA synthesis was not detectable in md-BYL, it was possible that the replication proteins synthesized in mdBYL were able to form the active RNA replication complex when membranes were supplemented. To test this possibility, we performed translation of ToMV RNA in mdBYL, followed by incubation with puromycin and membranes that had been recovered in the pellet fraction after centrifugation of BYL at 30,000 ϫ g (P30BYL), and then carried out the RdRP reaction. As shown in Fig. 1B and C (lanes 5 and 6), the (Ϫ)RNA, as well as the genomic and subgenomic (ϩ)RNAs, was synthesized in patterns similar to and in amounts larger than those observed in the standard reaction using BYL. A similar result was obtained when membranes that were further purified from P30BYL by the flotation method using sucrose gradient centrifugation were added to the ToMV RNA-translated mdBYL (data not shown), which confirms that membranes are essential for the synthesis of (Ϫ)RNA and other ToMV-related RNAs.
The P100 fraction of ToMV RNA-translated mdBYL contains components essential for the formation of ToMV RNA replication complex on membranes. To investigate the molecular basis for the ability to form RNA replication complexes when mixed with P30BYL membranes, as observed for ToMV RNAtranslated mdBYL, we first fractionated ToMV RNA-translated mdBYL by centrifugation at 100,000 ϫ g. ToMV 130K and 180K proteins were recovered both in the pellet fraction (mdP100 [ToMV] ) and in the supernatant fraction (mdS100[ToMV]) ( Fig.  2A) . When the fractions were incubated with P30BYL membranes, followed by the RdRP reaction, the mdP100[ToMV] fraction but not the mdS100[ToMV] fraction was able to synthesize ToMV-related RNAs (data not shown). To examine whether the inability of the replication proteins in the mdS100[ToMV] fraction to support ToMV RNA replication was caused by the lack of ToMV RNA or other host factors that fractionated only into the Fig. 2B , the reaction mixtures that contained the mdP100[ToMV] fraction gave synthesis of ToMV-related RNAs, irrespective of the types of mdS100 or the addition of exogenous ToMV RNA (lanes 3, 4, 7, and 8).
These results indicate that the mdP100[ToMV] fraction contains ToMV RNA, which serves as an endogenous template for replication, as well as the replication proteins, which are capable of forming the active RNA replication complex on membranes. In contrast, although the mdS100[ToMV] fraction contained substantial amounts of the replication proteins, this fraction was incapable of synthesizing ToMV-related RNAs even when ToMV RNA, the mdP100[mock] fraction, and P30BYL membranes were supplied (Fig. 2B, lanes 1, 2, 5 , and 6).
In order to examine more precisely the properties of the replication proteins in ToMV RNA-translated mdBYL, the translation mixture was applied to the top of the 15 to 40% (wt/vol) continuous sucrose density gradient and centrifuged at 100,000 ϫ g for 2 h. After fractionation (fractions 1 to 10, from the top to the bottom of the gradient), each fraction was subjected to Northern and Western analyses to detect ToMV RNA and the replication proteins, respectively. ToMV RNA was fractionated mainly in the fifth and sixth fractions, while the 130K and 180K replication proteins showed fractionation patterns with two peaks at the first-second and fifth-sixth fractions ( Fig. 3A and B) . The sixth fraction contained the 80S ribosomes (data not shown). In the sucrose gradient centrifugation analysis, the replication proteins in the mdS100[ToMV] fraction were fractionated mainly in the first-second fractions, whereas those in the mdP100[ToMV] fraction were in the fifth-sixth fractions (data not shown). When the fractions were incubated with P30BYL membranes followed by the RdRP reaction, ToMV-related RNA synthesis was observed for the fifth-sixth fractions, which contained both the ToMV replication proteins and ToMV RNA (Fig. 3C) .
The complex that forms the active ToMV RNA replication complex on membranes contains the ToMV 130K and 180K replication proteins and genomic RNA. Although the fifth and sixth (approximately 70S) fractions of the sucrose gradient contained both the ToMV replication proteins and ToMV RNA (Fig. 3) , it was not clear whether these components were associated with each other in these fractions. To address whether these molecules form a complex, we performed affinity purification of the 180K replication protein using a replication-competent ToMV RNA derivative, TL180SF. This derivative encodes the 180K protein, the C terminus of which is fused to the FLAG tag, while retaining the unmodified 130K protein and carries a deletion in the 30-kDa protein and coat protein coding regions (Fig.  4A) . The modification of the 180K protein did not impair the ability of the 180K protein to support ToMV RNA replication in BY-2 cells and in BYL (Fig. 4D, lanes 1 and 2) (23) .
TL180SF RNA was translated in mdBYL, followed by centrifugation at 100,000 ϫ g to give the pellet (mdP100[TL180SF]) fraction. The FLAG-tagged 180K protein in the mdP100
[TL180SF] fraction was affinity purified using anti-FLAG immunoglobulin G-conjugated agarose beads. As a control, TLW3 RNA, the wild-type in vitro transcript equivalent to ToMV RNA (we call the in vitro transcript "TLW3" to distinguish it from ToMV RNA isolated from virions) (17) was used. The 180K and 130K proteins were readily detected by Western analysis in the FLAG-purified fraction from the mdP100[TL180SF] fraction, whereas these proteins were barely detectable in the same fraction from the mdP100[TLW3] fraction (Fig. 4C, lanes 3 and 4) . Northern analyses revealed that the genomic RNA specifically copurified with the FLAG-tagged 180K protein (Fig. 4B, lanes 3  and 4) . ToMV RNA replication was observed when P30BYL membranes were added to the FLAG-purified fraction for TL180SF but not for TLW3 (Fig. 4D, lanes 3 and 4) . Taken together, these results suggest that in the mdP100[ToMV] fraction, the 130K and 180K proteins and ToMV RNA form a ribonucleoprotein complex, which is eventually converted into an active RNA replication complex on membranes. We call this ribonucleoprotein complex the "ToMV pre-membrane-targeting complex" (PMTC). 
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The 180K protein in the mdS100[TL180] fraction participates in replication of TL130 RNA in the mdP100[TL130] fraction. To gain further insights into the assembly of the PMTC, we constructed the ToMV RNA derivatives TL130 and TL180. TL130 has a large deletion in the read-through region of the 180K protein, 30-kDa protein, and coat protein coding regions and expresses the 130K protein alone (Fig. 5A ). TL180 is a derivative of TLW3 that has a point mutation that alters the termination codon of the 130K protein ORF to the tyrosine codon and expresses the 180K protein but not the 130K protein (Fig. 5A) . TL180 RNA could replicate by itself, albeit at a lower efficiency than wild-type TLW3 RNA, while 180K protein-deficient ToMV derivatives could not replicate by themselves in BY-2 cells (11, 12 ; data not shown).
The in vitro transcripts of TL130 and TL180 were separately translated in mdBYL, the reaction mixtures were fractionated fractions. These fractions were mixed as indicated in panel B and were incubated at 15°C for 30 min. To each mixture (25 l), the P30BYL membrane suspension (1/20 volume of the resulting mixture) and puromycin (0.2 mM in the resulting mixtures) were added, and incubation was performed at 15°C for 1 h. After this incubation period, an aliquot of each sample was removed for protein analysis for panel B, and the remainder was subjected to the RdRP reaction for panel C. For panel B, the 130K and 180K replication proteins were detected by the Western blotting method as described in the legend to Fig. 1 . For panel C, the RdRP reaction was carried out in the presence of [␣-32 P]CTP, and the reaction products were analyzed as described in the legend to Fig. 1 . For panel D, the 32 P-labeled RNA products analyzed in panel C were treated with S1 nuclease. S1 nuclease-resistant RNA was separated by 8 M urea-2.4% PAGE, and the 32 P- into the P100 and S100 fractions (mdP100[TL130], mdS100 [TL130], mdP100[TL180], and mdS100[TL180]), and each fraction was subjected to the RdRP reaction following incubation with P30BYL membranes. As expected, only the mdP100 [TL180] fraction showed a detectable level of viral RNA synthesis ( Fig. 5C and D, lanes 1 to 4) . Although a faint band that corresponds to the TL130 genomic RNA was observed in the mdP100[TL130] fraction (Fig. 5C, lane 2) , this does not represent replication, since the genome-length double-stranded RNA (replicative form) band was not detected, even after S1 nuclease treatment (Fig. 5D, lane 2) . Instead, this band probably represents terminal labeling of the input TL130 RNA by host ATP(CTP):tRNA nucleotidyltransferase (1). We mixed these fractions in all possible heterologous combinations, incubated the mixtures with P30BYL membranes, and then performed the RdRP reaction. When the mdP100[TL130] and mdS100[TL180] fractions were mixed, the replication of TL130 RNA was observed (Fig. 5C and D, lane 7) , which suggests that a PMTC-like complex is formed in TL130-translated mdBYL and that the 180K protein in the mdS100[TL180] fraction contributes to the replication of TL130 RNA contained in the PMTC-like complex. When the mdP100[TL130] and mdP100 [TL180] fractions were mixed, strong replication of TL130 RNA was observed ( Fig. 5C and D, lane 8) . The level of TL180 RNA replication was not remarkably altered by the presence of the 130K protein (compare lanes 6 and 8 with lane 4 in Fig.  5C and D) , which suggests that the 130K protein does not contribute to the replication of TL180 RNA in trans. In the combination of the mdS100[TL130] and mdS100[TL180] fractions, ToMV-related RNA replication was not detected (Fig.  5C and D, lane 5) . This result is consistent with the absence of PMTC (or PMTC-like complexes) in the mdS100 fractions.
PMTC is able to accept exogenous ToMV-related RNAs as replication templates. We next examined whether PMTC could accept exogenous RNA as replication templates. As a model replicon, a derivative of ToMV RNA, termed D1 RNA, that carries a deletion between nucleotides 1346 to 5655 was used (Fig. 6A) . D1 RNA mimics the well-characterized TMV RNA derivative ⌬Cla, which does not code for intact replication proteins but can be replicated efficiently with the assistance of wild-type helper TMV RNA in protoplasts (19) .
D1 RNA was incubated with the mdP100[ToMV] fraction that contained puromycin, and then an RdRP reaction was carried out after incubation with P30BYL membranes. As a control, a capped Rluc mRNA carrying an A 30 tract was used in place of D1 RNA. As shown in Fig. 6B , singlestranded and double-stranded D1 RNAs were synthesized (lane 4), which was not the case when the mdP100[mock] fraction was used (lane 3) or when D1 RNA was omitted (lane 2). In contrast, Rluc RNA-specific bands were not detected (lane 6). These results suggest that the D1 RNA was specifically recognized by PMTC and was replicated. The replication of D1 RNA was not observed when the mixture of mdS100[ToMV] and mdP100[mock] fractions was used (data not shown), which confirms that the replication proteins in the mdS100[ToMV] fraction lack the ability to replicate ToMV-related RNAs. Finally, we examined whether the order of the addition of D1 RNA and P30BYL membranes affected the efficiency of D1 RNA replication. As shown in Fig. 6C , the replication of D1 RNA was not ments that are inaccessible to cytoplasmic macromolecules (23, 30) .
DISCUSSION
The purpose of this study was to dissect the process of ToMV RNA replication complex formation in vitro. Initially, we showed that the initiation of ToMV (Ϫ)RNA synthesis requires membranes (Fig. 1) . We then showed that a ribonucleoprotein complex named PMTC, which contains the genomic RNA and the 130K and 180K replication proteins, is formed in ToMV RNAtranslated mdBYL (Fig. 4) . The PMTC had an approximate sedimentation coefficient of 70S (Fig. 3) and was fractionated into the P100 (mdP100[ToMV]) fraction (Fig. 2) . While PMTC itself did not have the ability to synthesize ToMV-related RNAs, it formed an RNA replication complex, which synthesized negativeand positive-strand ToMV RNAs, when mixed with P30BYL membranes (Fig. 1 to 4) . These results suggest that PMTC is an intermediate of ToMV RNA replication complex formation.
The 130K and 180K replication proteins synthesized by translation of ToMV RNA in mdBYL were fractionated not only into the P100 fraction but also into the S100 (mdS 100[ToMV]) fraction. The replication proteins in the mdS100 [ToMV] fraction were not able to replicate exogenously added ToMV RNA (Fig. 2) or D1 RNA (data not shown) even in the presence of membranes and rNTPs, which suggests that PMTC formation occurs only when coupled with the translation of ToMV RNA. It is possible that ToMV replication proteins recognize ToMV RNA either during or immediately after translation or that ToMV replication proteins recognize a specific RNA structure that is transiently formed on ToMV RNA after the passage of ribosomes.
When the mdP100[TL130] and mdS100[TL180] fractions were mixed and incubated with P30BYL membranes and rNTPs, the replication of TL130 RNA occurred (Fig. 5, lane 7) . This result suggests that one or more 130K protein molecules bind cotranslationally to a TL130 RNA molecule and that the 180K protein (and perhaps an additional 130K protein) binds posttranslationally to the 130K protein-TL130 RNA complex to form PMTC. We propose to call this cotranslationally formed, 130K protein-viral RNA complex the "core PMTC." On the other hand, when the mdP100[TL180] fraction alone was incubated with P30BYL membranes and rNTPs, the replication of TL180 RNA was observed (Fig. 5, lane 4) . When the mdP100[TL180] fraction was mixed with the mdP100[TL130] fraction, followed by incubation with P30BYL membranes and rNTPs, not only the replication of TL180 RNA but also more active replication of TL130 RNA was observed (Fig. 5, lane 8) . These results suggest that the 180K protein alone can form core PMTC at lower efficiency than the 130K protein. Thus, in the wild-type context, in which both the 130K and 180K proteins are expressed from the same translation template, PMTC appears to be established mainly through the cotranslational formation of the 130K protein-ToMV RNA complex (core PMTC), followed by posttranslational binding of the 180K protein (and perhaps an additional 130K protein) to the core PMTC. The 180K protein may acquire the ability to synthesize (Ϫ)RNA through binding to core PMTC and the subsequent interactions with membranes and host proteins.
In keeping with these possibilities, Lewandowski and colleagues found that some deletion derivatives of TMV RNAs (defective RNAs) that encode the 130K protein alone can be replicated in plant cells when helper TMV RNA derivatives that express the 180K protein are coinoculated; however, frame-shift and other deleterious mutations in the 130K protein ORF in the defective RNA greatly reduce the efficiency of defective RNA replication. From these observations, these authors proposed a model in which the 130K protein first binds to its translation template (i.e., defective RNA) in cis, the 180K protein is then incorporated into this complex, and finally, the synthesis of (Ϫ)RNA occurs (19, 20) . It is reasonable to assume that the replication proteins preferentially select their translation template as the replication template (i.e., in cis), since the closest replication template for nascent replication protein is its own translation template for positive-strand RNA viruses with nonsegmented genomes. Taking into consideration the fact that core PMTC is cotranslationally formed, it is assumed that the cis preference is much stronger. We have also demonstrated that a deletion derivative of ToMV RNA, D1, is replicated when D1 RNA is mixed with PMTC and then with P30BYL membranes and rNTPs. In the in vitro system, translation of D1 RNA was not required for D1 RNA to be replicated (Fig. 6B, lane 4) . In contrast, translation of at least a certain part of the 130K protein ORF is necessary for defective RNAs to be replicated efficiently by helper viruses in vivo (20) . To explain this contradiction, we propose two alternative pathways of defective RNA replication: (i) through posttranslational, transrecognition of defective RNA by PMTC supplied by helper RNA and (ii) through cotranslational formation of core PMTC (or core PMTC-like complex) on the defective RNA molecule, followed by recruitment of the 180K protein (and perhaps the 130K protein) supplied by helper RNA. In vivo, pathway ii would be more active than pathway i. The presence of membranes during translation may contribute to this effect. In vitro, where D1 RNA was incubated with helper RNA-derived PMTC in the presence of puromycin and in the absence of membranes, only pathway i would occur. Considering that core PMTC is formed cotranslationally, it seems unlikely that the replication protein in the core PMTC detaches from the translation template and then binds again to D1 RNA. Rather, it is plausible to postulate that independently of the translation template RNA-binding site of the replication protein in core PMTC, the PMTC has one or more additional template RNA-binding sites that are open for exogenous templates.
